Tag
"The language of chronic illness often sets up a relationship of a winner and loser, successes and failures. It makes me feel if I’m struggling with my symptoms or if I ‘fail’ my medication, I’m not fighting hard enough or being a strong enough warrior.”
Were you affected by the abatacept (Orencia®) shortage this year? If so, we have great news. The supply situation in Australia has improved and you may be able to return to your previous treatment regime.
Australians with moderate to severe lupus now have affordable access to a targeted treatment via the PBS for the first time.
Do you use abatacept (Orencia®) to treat your inflammatory arthritis? Australia has a shortage of both the ClickJect (autoinjector) and pre-filled syringe subcutaneous formulations of abatacept. Here’s what you need to do.
Were you transitioned to another medicine during the tocilizumab (Actemra®) shortage? Now that it is available again, you can speak with your rheumatologist about your ongoing treatment options.
Do you use Orencia to treat your inflammatory arthritis? Have you been affected by the current supply shortage? Here are the options available to you.
What will the current COVID-19 vaccine candidates mean for Australians with autoimmune conditions? Can we take them? When will we get them?
Ixekizumab (Taltz®) is a new treatment option for Australians with ankylosing spondylitis - a chronic form of arthritis that affects the spine and pelvis.
It can be a big adjustment to give yourself injections. These tips can make the process less scary.
Do you use a biologic medication for your inflammatory arthritis? Do you know about biosimilars? Discover the basics as part of Biosimilar Awareness Week.
